INSM1 and carcinoid tumor: In a study that tested both markers in typical carcinoids, atypical carcinoids, SCLCs, and LCNECs, researchers found that though the overall sensitivity of STX1 in these samples was very high (96.6%), INSM1 outperformed the marker (97.7%) [45].